JPRN-UMIN000003928已完成未知
A clinical investigation of SM-01 stenting versus balloon angioplasty for the treatment of superficial femoral artery disease. - SM-01
Johnson and Johnson K.K. Medical Company0 个研究点目标入组 100 人开始时间: 2010年7月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Recent hemorrhagic disease within the past 3 months. 2. Aneurysm in the SFA or popliteal artery. 3. Acute limb occlusion. 4. Procedures which are pre-determined to require stent-in-stent placement to obtain patency, such as severe calcification which is resistant to stenting, or for in-stent restenosis. 5. Poor iliac or common femoral "inflow".(However, intervention to restore adequate blood flow prior to the treatment of the study lesion is allowed.) 6. Known allergies to aspirin, heparin, or ticlopidine, or bleeding diathesis. 7. Patients unable or unwilling to tolerate anticoagulant or antiplatelet therapy. 8. Patients unable or unwilling to tolerate contrast agents used in intravascular procedures. 9. Allergic to nitinol or tantalum. 10. Women who are pregnant or lactating, or of child bearing potential, or with a desire to be a parent during the study period. 11. Significant vessel tortuosity or other parameters prohibiting access to the lesion or which would prevent delivery of the stent device. 12. Revascularization involving the same limb 30 days prior to the index procedure or a planned re-vascularization within 30 days after the index procedure. 13. Previously implanted stent(s) at the same site in the artery to be treated. 14. Requiring stent placement in the distal SFA or popliteal artery. 15. Presence of a femoral artificial graft. 16. History of participating in any other clinical study within 1 year. 17. Life expectancy less than 3 years, or any other factors preventing clinical follow-up. 18. Receiving dialysis or immunosuppressant therapy 19. Serum creatinine level >= 2.0 mg/dL before procedure. 20. A principal investigator or a co-principal investigator determines that patient is unsuitable for this study.
研究者
相似试验
已完成
3 期
A Clinical Investigation of SM-01 Stenting Versus PTA for the Treatment of Superficial Femoral Artery DiseasePeripheral Vascular DiseasesNCT01183117Johnson & Johnson K.K. Medical Company105
已完成
不适用
Prospective randomised trial of stented versus stentless bioprosthesis for aortic valve replacement (AVR)Aortic valve replacementCirculatory SystemISRCTN56511757Papworth Hospital NHS Trust (UK)240
已完成
不适用
Study on the effectiveness of stenting for obstructive colorectal cancer at Niigata City HospitalObstructive colorectal cancerJPRN-UMIN000040771iigata City General Hospital85
Unknown
不适用
Stenting With or Without Coating Compared With Angioplasty in Non-benestent DiseaseCoronary Artery DiseaseNCT00192881Rigshospitalet, Denmark
已完成
不适用
Efficacy and safety of inside stent in patients with biliary stricture: a prospective multicenter studybenign and malignant biliary strictureJPRN-UMIN000013291Inside Stent Study Group134